In heart failure patients, greater than 50% increases in BUN were observed in 16.6% of valsartan-treated patients compared to 6.3% of placebo-treated patients [see Warnings and Precautions (5.4)]
von LintigJMoonJLeeJRamkumarS
External resources American Journal of Clinical Nutrition: Nutritional priorities to support GLP-1 therapy for obesity Endocrine Society: Protein may protect against muscle loss on semaglutide (ENDO 2025) Impact of semaglutide on body composition in adults with overweight or obesity: STEP 1 study For researchers serious about optimizing their peptide protocols and nutrition strategies during GLP-1 therapy, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, personalized calculators, and a community of thousands who have navigated these exact questions
Lemon Bottle is promoted as a local fat dissolver
Light-it designed and developed a custom platform that lets patients book and join virtual consultations, request prescriptions, and track their medication history, all while staying connected to care teams
Caution should be exercised in person with known hypersensitivity to any of the ingredients